Robert Moumdjian
Overview
Explore the profile of Robert Moumdjian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Charabati M, Zandee S, Fournier A, Tastet O, Thai K, Zaminpeyma R, et al.
Brain
. 2022 Nov;
146(4):1483-1495.
PMID: 36319587
The trafficking of autoreactive leucocytes across the blood-brain barrier endothelium is a hallmark of multiple sclerosis pathogenesis. Although the blood-brain barrier endothelium represents one of the main CNS borders to...
2.
Fournier A, Zandee S, Charabati M, Peelen E, Tastet O, Ivan Alvarez J, et al.
Neurol Neuroimmunol Neuroinflamm
. 2022 Oct;
9(6).
PMID: 36241608
Background And Objectives: In multiple sclerosis (MS), peripheral immune cells use various cell trafficking molecules to infiltrate the CNS where they cause damage.The objective of this study was to investigate...
3.
Charabati M, Grasmuck C, Ghannam S, Bourbonniere L, Fournier A, Lecuyer M, et al.
Sci Transl Med
. 2022 Jan;
14(626):eabj0473.
PMID: 34985970
The migration of circulating leukocytes into the central nervous system (CNS) is a key driver of multiple sclerosis (MS) pathogenesis. The monoclonal antibody natalizumab proved that pharmaceutically obstructing this process...
4.
Quinones M, Belanger K, Lemieux Blanchard E, Lemieux B, Bahary J, Masucci L, et al.
Curr Oncol
. 2021 Aug;
28(4):3104-3114.
PMID: 34436037
Medulloblastoma is an aggressive primary brain tumor that is extremely rare in adults; therefore, prospective studies are limited. We reviewed the information of all MB patients treated at the CHUM...
5.
Broux B, Zandee S, Gowing E, Charabati M, Lecuyer M, Tastet O, et al.
Neurol Neuroimmunol Neuroinflamm
. 2020 Aug;
7(6).
PMID: 32788322
Objective: To investigate the involvement of interleukin (IL)-26 in neuroinflammatory processes in multiple sclerosis (MS), in particular in blood-brain barrier (BBB) integrity. Methods: Expression of IL-26 was measured in serum,...
6.
Michel L, Grasmuck C, Charabati M, Lecuyer M, Zandee S, Dhaeze T, et al.
Sci Transl Med
. 2019 Nov;
11(518).
PMID: 31723036
The presence of B lymphocyte-associated oligoclonal immunoglobulins in the cerebrospinal fluid is a classic hallmark of multiple sclerosis (MS). The clinical efficacy of anti-CD20 therapies supports a major role for...
7.
Dhaeze T, Tremblay L, Lachance C, Peelen E, Zandee S, Grasmuck C, et al.
Cell Mol Immunol
. 2019 Jan;
16(7):652-665.
PMID: 30635649
CD70 is the unique ligand of CD27 and is expressed on immune cells only upon activation. Therefore, engagement of the costimulatory CD27/CD70 pathway is solely dependent on upregulation of CD70....
8.
Obaid S, Nikolaidis I, Alzahrani M, Moumdjian R, Saliba I
J Audiol Otol
. 2018 Aug;
22(4):236-243.
PMID: 30130845
Background And Objectives: Controversy related to the choice of surgical approach for vestibular schwannoma (VS) resection remains. Whether the retrosigmoid (RS) or translabyrinthine (TL) approach should be performed is a...
9.
Moderie C, Maniakas A, Moumdjian R, Alhabib S, Saliba I
J Int Adv Otol
. 2017 Aug;
13(2):191-194.
PMID: 28816691
Objective: Rhinoliquorrhea is defined as a cerebrospinal fluid leakage from the nose. Our objective in this study is to determine the reduction of rhinoliquorrhea rates by Eustachian tube (ET) obliteration...
10.
Champagne P, Desrosiers M, Moumdjian R
Clin Neurol Neurosurg
. 2014 Mar;
119:106-9.
PMID: 24635937
No abstract available.